Top Health Official Promotes Drugs His Own Agency Is Reviewing

On July 23–24, 2026, an FDA advisory panel meets to review seven peptides — tiny protein-based compounds some pharmacies custom-make. Health Secretary Kennedy, who oversees the FDA, says he uses them personally with "really good effect" and accuses the agency of a "war on public health." FDA staff say the evidence doesn't yet prove they're safe or effective.